RFVIIA is effective alternative to APCC in prophylaxis of bleeding during immune tolerance protocol in haemophiliac with inhibitor - Blatny,J.; Kohlerova,S.; Zapletal,O.; Fiamoli,V.; Penka,M. (J Thromb Haemost, 2007)